Human Papillomavirus (HPV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Publisher Name :
Date: 01-Oct-2017
No. of pages: 157

Human Papillomavirus (HPV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Human Papillomavirus (HPV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Human Papillomavirus (HPV) Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Human Papillomavirus (HPV) Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Human Papillomavirus (HPV) Diagnostic Tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Human Papillomavirus (HPV) Diagnostic Tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Human Papillomavirus (HPV) Diagnostic Tests under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

Human Papillomavirus (HPV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Human Papillomavirus (HPV) Diagnostic Tests Overview 9
3 Products under Development 10
3.1 Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Stage of Development 10
3.2 Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Territory 11
3.3 Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Regulatory Path 12
3.4 Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Estimated Approval Date 13
3.5 Human Papillomavirus (HPV) Diagnostic Tests - Ongoing Clinical Trials 14
4 Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products under Development by Companies 15
4.1 Human Papillomavirus (HPV) Diagnostic Tests Companies - Pipeline Products by Stage of Development 15
4.2 Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Stage of Development 17
5 Human Papillomavirus (HPV) Diagnostic Tests Companies and Product Overview 19
5.1 Aalto Bio Reagents Ltd Company Overview 19
5.1.1 Aalto Bio Reagents Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Adaltis S.r.l. Company Overview 20
5.2.1 Adaltis S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 AutoGenomics Inc Company Overview 39
5.3.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.4 Beckman Coulter Inc Company Overview 41
5.4.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.5 Becton Dickinson and Co Company Overview 42
5.5.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 42
5.6 Biocartis SA Company Overview 47
5.6.1 Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 47
5.7 BioHelix Corp Company Overview 48
5.7.1 BioHelix Corp Pipeline Products & Ongoing Clinical Trials Overview 48
5.8 Biomagnetics Diagnostics Corporation Company Overview 49
5.8.1 Biomagnetics Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 49
5.9 Bioorganic Research and Services SA Company Overview 50
5.9.1 Bioorganic Research and Services SA Pipeline Products & Ongoing Clinical Trials Overview 50
5.10 Cepheid Company Overview 51
5.10.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 51
5.11 China Medical Technologies Inc (Inactive) Company Overview 52
5.11.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 52
5.12 Co-Diagnostics HBDC, Inc. Company Overview 53
5.12.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.13 Enigma Diagnostics Ltd (Inactive) Company Overview 54
5.13.1 Enigma Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54
5.14 Enzo Life Sciences Inc Company Overview 55
5.14.1 Enzo Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 55
5.15 Genera Biosystems Ltd Company Overview 56
5.15.1 Genera Biosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
5.16 Genome Diagnostics Pvt. Ltd. Company Overview 60
5.16.1 Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 60
5.17 German Cancer Research Center Company Overview 61
5.17.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 61
5.18 Goodgene Inc Company Overview 62
5.18.1 Goodgene Inc Pipeline Products & Ongoing Clinical Trials Overview 62
5.19 Great Basin Scientific Inc Company Overview 63
5.19.1 Great Basin Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 63
5.20 HEALTH BioMed Co Ltd Company Overview 64
5.20.1 HEALTH BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 64
5.21 HistoGeneX NV Company Overview 65
5.21.1 HistoGeneX NV Pipeline Products & Ongoing Clinical Trials Overview 65
5.22 Homepoint Testing Company Overview 66
5.22.1 Homepoint Testing Pipeline Products & Ongoing Clinical Trials Overview 66
5.23 IncellDx Inc Company Overview 67
5.23.1 IncellDx Inc Pipeline Products & Ongoing Clinical Trials Overview 67
5.24 KogeneBiotech Co Ltd Company Overview 68
5.24.1 KogeneBiotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 68
5.25 MEDITE Cancer Diagnostics Inc Company Overview 69
5.25.1 MEDITE Cancer Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.26 MedNostic Technologies, LLC Company Overview 70
5.26.1 MedNostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 70
5.27 Monogram Biosciences Inc Company Overview 71
5.27.1 Monogram Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 71
5.28 Novacyt SA Company Overview 72
5.28.1 Novacyt SA Pipeline Products & Ongoing Clinical Trials Overview 72
5.29 OncoHealth Corp (Inactive) Company Overview 73
5.29.1 OncoHealth Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 73
5.30 Pathogenica Inc Company Overview 75
5.30.1 Pathogenica Inc Pipeline Products & Ongoing Clinical Trials Overview 75
5.31 Provista Diagnostics Inc Company Overview 76
5.31.1 Provista Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 76
5.32 Qiagen NV Company Overview 78
5.32.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 78
5.33 Rheonix Inc Company Overview 80
5.33.1 Rheonix Inc Pipeline Products & Ongoing Clinical Trials Overview 80
5.34 Sansure Biotech Inc Company Overview 81
5.34.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 81
5.35 Seattle Children's Hospital Company Overview 83
5.35.1 Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 83
5.36 Sequenom Inc Company Overview 84
5.36.1 Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview 84
5.37 The Feinstein Institute for Medical Research Company Overview 87
5.37.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 87
5.38 TrovaGene Inc Company Overview 88
5.38.1 TrovaGene Inc Pipeline Products & Ongoing Clinical Trials Overview 88
5.39 University of Queensland Company Overview 89
5.39.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 89
5.40 University of Texas at Austin Company Overview 90
5.40.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 90
5.41 ValiRx Plc Company Overview 91
5.41.1 ValiRx Plc Pipeline Products & Ongoing Clinical Trials Overview 91
5.42 Yale University Company Overview 92
5.42.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 92
6 Human Papillomavirus (HPV) Diagnostic Tests - Recent Developments 93
6.1 Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson 93
6.2 Aug 14, 2017: MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results 93
6.3 Aug 09, 2017: Trovagene Announces Second Quarter 2017 Company Highlights and Financial Results 95
6.4 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter 97
6.5 Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 98
6.6 Aug 01, 2017: Novel Genetic Test Could Help Combat the Opioid Epidemic by Identifying Patients at Risk of Addiction 100
6.7 Jul 27, 2017: QIAGEN Reports Results for Second Quarter and First Half of 2017 101
6.8 Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results 104
6.9 Jul 10, 2017: Trovagene Regains Compliance with NASDAQ Listing Requirements 106
6.10 Jun 22, 2017: HPV testing leads to earlier detection and treatment of cervical pre-cancer 106
6.11 Jun 06, 2017: BD Releases 2016 Sustainability Report 107
6.12 May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 107
6.13 May 10, 2017: Trovagene Announces First Quarter 2017 Company Highlights and Financial Results 108
6.14 May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 109
6.15 May 10, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 111
6.16 May 05, 2017: ValiRx: Final Results for the Year Ended 31 December 2016 111
6.17 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter 114
6.18 May 02, 2017: QIAGEN reports results for first quarter 2017 116
6.19 Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 118
6.20 Apr 27, 2017: MEDITE Cancer Diagnostics Appoints Susan Weisman as Chief Financial Officer 119
6.21 Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results 119
6.22 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President 120
6.23 Apr 18, 2017: ValiRx: Change of Registered Office 121
6.24 Apr 13, 2017: Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board 121
6.25 Mar 28, 2017: Roche Announces Launch Of Cobas HPV On The Cobas 6800/8800 Systems For Cervical Cancer Screening In Markets Accepting The CE Mark 122
6.26 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management 123
6.27 Mar 21, 2017: Retractable Technologies Announces Litigation Updates 124
6.28 Mar 15, 2017: Trovagene Reports Fourth Quarter and Year End 2016 Financial Results 124
6.29 Mar 07, 2017: MEDITE Cancer Diagnostics Appoints Eric M. Goehausen to Board of Directors 125
6.30 Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results 126
6.31 Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter 127
6.32 Feb 01, 2017: QIAGEN Reports Results for Fourth Quarter and Full-year 2016 129
6.33 Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 132
6.34 Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories 134
6.35 Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016 135
6.36 Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 135
6.37 Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors 136
6.38 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe 136
6.39 Nov 09, 2016: Trovagene Reports Third Quarter 2016 Financial Results and Accomplishments 137
6.40 Nov 07, 2016: Trovagene Announces HPV Patent Issuance by U.S. Patent and Trademark Office, Broadening Its Precision Cancer Monitoring IP Portfolio 138
6.41 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 139
6.42 Nov 02, 2016: QIAGEN Reports Results for Third Quarter and First Nine Months of 2016 140
6.43 Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 144
6.44 Nov 02, 2016: QIAGEN launches restructuring initiatives, revises outlook for 2016 earnings and provides initial net sales and adjusted earnings guidance for 2017 145
6.45 Oct 26, 2016: Quidel Reports Third Quarter 2016 Financial Results 146
6.46 Oct 19, 2016: GeneFirst Announces CE Marking and Release of Papilloplex HR-HPV, a PCR Based Molecular Diagnostic Test for Genotyping 14 High Risk Human Papillomaviruses from Cervical and Urine Samples 147
6.47 Oct 03, 2016: Genera Biosystems Limited Receipt Of Data For Paptype 2,000 Specimens In US Based Screening Population 148
6.48 Oct 03, 2016: Genera Biosystems: 2016 Annual Report Highlights 149
6.49 Sep 27, 2016: ValiRx: Half Yearly Report for the Period Ended 30 June 2016 151
7 Appendix 154
7.1 Methodology 154
7.2 About GlobalData 157
7.3 Contact Us 157
7.4 Disclaimer 157

1.1 List of Tables
Table 1: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Stage of Development 10
Table 2: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Territory 11
Table 3: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Regulatory Path 12
Table 4: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Estimated Approval Date 13
Table 5: Human Papillomavirus (HPV) Diagnostic Tests - Ongoing Clinical Trials 14
Table 6: Human Papillomavirus (HPV) Diagnostic Tests Companies - Pipeline Products by Stage of Development 15
Table 7: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Stage of Development 17
Table 8: Aalto Bio Reagents Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
Table 9: AaltoCC - HPV - Product Status 19
Table 10: AaltoCC - HPV - Product Description 19
Table 11: Adaltis S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 12: MOLgen DNA HPV 16/18 Set 1 Kit - Product Status 21
Table 13: MOLgen DNA HPV 16/18 Set 1 Kit - Product Description 21
Table 14: MOLgen DNA HPV 16/18 Set 2 Kit - Product Status 21
Table 15: MOLgen DNA HPV 16/18 Set 2 Kit - Product Description 22
Table 16: MOLgen DNA HPV 26/51 Set 1 Kit - Product Status 22
Table 17: MOLgen DNA HPV 26/51 Set 1 Kit - Product Description 22
Table 18: MOLgen DNA HPV 26/51 Set 2 Kit - Product Status 23
Table 19: MOLgen DNA HPV 26/51 Set 2 Kit - Product Description 23
Table 20: MOLgen DNA HPV 26/53/66 Set 1 Kit - Product Status 23
Table 21: MOLgen DNA HPV 26/53/66 Set 1 Kit - Product Description 24
Table 22: MOLgen DNA HPV 26/53/66 Set 2 Kit - Product Status 24
Table 23: MOLgen DNA HPV 26/53/66 Set 2 Kit - Product Description 24
Table 24: MOLgen DNA HPV 31/33 Set 1 Kit - Product Status 25
Table 25: MOLgen DNA HPV 31/33 Set 1 Kit - Product Description 25
Table 26: MOLgen DNA HPV 31/33 Set 2 Kit - Product Status 25
Table 27: MOLgen DNA HPV 31/33 Set 2 Kit - Product Description 26
Table 28: MOLgen DNA HPV 35/45 Set 1 Kit - Product Status 26
Table 29: MOLgen DNA HPV 35/45 Set 1 Kit - Product Description 26
Table 30: MOLgen DNA HPV 35/45 Set 2 Kit - Product Status 27
Table 31: MOLgen DNA HPV 35/45 Set 2 Kit - Product Description 27
Table 32: MOLgen DNA HPV 44 Set 1 Kit - Product Status 27
Table 33: MOLgen DNA HPV 44 Set 1 Kit - Product Description 28
Table 34: MOLgen DNA HPV 44 Set 2 Kit - Product Status 28
Table 35: MOLgen DNA HPV 44 Set 2 Kit - Product Description 28
Table 36: MOLgen DNA HPV 6/11 Set 1 Kit - Product Status 29
Table 37: MOLgen DNA HPV 6/11 Set 1 Kit - Product Description 29
Table 38: MOLgen DNA HPV 6/11 Set 2 Kit - Product Status 29
Table 39: MOLgen DNA HPV 6/11 Set 2 Kit - Product Description 30
Table 40: MOLgen DNA HPV 6/11/44 Set 1 Kit - Product Status 30
Table 41: MOLgen DNA HPV 6/11/44 Set 1 Kit - Product Description 30
Table 42: MOLgen DNA HPV 6/11/44 Set 2 Kit - Product Status 31
Table 43: MOLgen DNA HPV 6/11/44 Set 2 Kit - Product Description 31
Table 44: MOLgen DNA HPV 66 Set 1 Kit - Product Status 31
Table 45: MOLgen DNA HPV 66 Set 1 Kit - Product Description 32
Table 46: MOLgen DNA HPV 66 Set 2 Kit - Product Status 32
Table 47: MOLgen DNA HPV 66 Set 2 Kit - Product Description 32
Table 48: MOLgen DNA HPV 68 Set 1 Kit - Product Status 32
Table 49: MOLgen DNA HPV 68 Set 1 Kit - Product Description 33
Table 50: MOLgen DNA HPV 68 Set 2 Kit - Product Status 33
Table 51: MOLgen DNA HPV 68 Set 2 Kit - Product Description 33
Table 52: MOLgen DNA HPV 68/73/82 Set 1 Kit - Product Status 33
Table 53: MOLgen DNA HPV 68/73/82 Set 1 Kit - Product Description 34
Table 54: MOLgen DNA HPV 68/73/82 Set 2 Kit - Product Status 34
Table 55: MOLgen DNA HPV 68/73/82 Set 2 Kit - Product Description 34
Table 56: MOLgen DNA HPV HCR Genotype Quantitative, Set 1 Kit - Product Status 35
Table 57: MOLgen DNA HPV HCR Genotype Quantitative, Set 1 Kit - Product Description 35
Table 58: MOLgen DNA HPV HCR Genotype Quantitative, Set 2 Kit - Product Status 35
Table 59: MOLgen DNA HPV HCR Genotype Quantitative, Set 2 Kit - Product Description 36
Table 60: MOLgen DNA HPV HCR Genotype Set 1 Kit - Product Status 36
Table 61: MOLgen DNA HPV HCR Genotype Set 1 Kit - Product Description 36
Table 62: MOLgen DNA HPV HCR Genotype Set 2 Kit - Product Status 37
Table 63: MOLgen DNA HPV HCR Genotype Set 2 Kit - Product Description 37
Table 64: MOLgen DNA HPV Screen Set 1 Kit - Product Status 37
Table 65: MOLgen DNA HPV Screen Set 1 Kit - Product Description 38
Table 66: MOLgen DNA HPV Screen Set 2 Kit - Product Status 38
Table 67: MOLgen DNA HPV Screen Set 2 Kit - Product Description 38
Table 68: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 69: INFINITI HPV Genotyping Assay - Product Status 39
Table 70: INFINITI HPV Genotyping Assay - Product Description 39
Table 71: INFINITI HPV-HR Quad Assay - Product Status 40
Table 72: INFINITI HPV-HR Quad Assay - Product Description 40
Table 73: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 74: DxN VERIS HPV Assay - Product Status 41
Table 75: DxN VERIS HPV Assay - Product Description 41
Table 76: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 42
Table 77: BD Max HPV Assay - Product Status 42
Table 78: BD Max HPV Assay - Product Description 43
Table 79: BD Onclarity HPV Assay - Product Status 43
Table 80: BD Onclarity HPV Assay - Product Description 43
Table 81: BD Viper LT System - HPV - Product Status 44
Table 82: BD Viper LT System - HPV - Product Description 44
Table 83: Becton Dickinson and Co - Ongoing Clinical Trials Overview 45
Table 84: BD Viper LT System - HPV - Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System with Cervical Specimens 46
Table 85: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 47
Table 86: Idylla HPV Test - Head & Neck Cancer - Product Status 47
Table 87: Idylla HPV Test - Head & Neck Cancer - Product Description 47
Table 88: BioHelix Corp Pipeline Products & Ongoing Clinical Trials Overview 48
Table 89: IsoAmp Assay - HPV - Product Status 48
Table 90: IsoAmp Assay - HPV - Product Description 48
Table 91: Biomagnetics Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 49
Table 92: Diagnostic Test - HPV - Product Status 49
Table 93: Diagnostic Test - HPV - Product Description 49
Table 94: Bioorganic Research and Services SA Pipeline Products & Ongoing Clinical Trials Overview 50
Table 95: BNTIVD002 Assay - HPV Immune Response Monitoring - Product Status 50
Table 96: BNTIVD002 Assay - HPV Immune Response Monitoring - Product Description 50
Table 97: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 51
Table 98: GeneXpert - Xpert HPV CLIA Waived - Product Status 51
Table 99: GeneXpert - Xpert HPV CLIA Waived - Product Description 51
Table 100: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 52
Table 101: SPR Based DNA Chip - Sexually Transmitted Diseases - Product Status 52
Table 102: SPR Based DNA Chip - Sexually Transmitted Diseases - Product Description 52
Table 103: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
Table 104: Co-Dx Test - Human Papillomavirus - Product Status 53
Table 105: Co-Dx Test - Human Papillomavirus - Product Description 53
Table 106: Enigma Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54
Table 107: Enigma MiniLab - HPV - Product Status 54
Table 108: Enigma MiniLab - HPV - Product Description 54
Table 109: Enzo Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 55
Table 110: Next-Generation Branched DNA Assay - HPV - Product Status 55
Table 111: Next-Generation Branched DNA Assay - HPV - Product Description 55
Table 112: Genera Biosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
Table 113: PapType - Product Status 56
Table 114: PapType - Product Description 57
Table 115: PapType SP - Product Status 57
Table 116: PapType SP - Product Description 57
Table 117: Genera Biosystems Ltd - Ongoing Clinical Trials Overview 58
Table 118: PapType - Predictors 3 Study 59
Table 119: Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 60
Table 120: Human Pappiloma Virus Real Time PCR Kit - Product Status 60
Table 121: Human Pappiloma Virus Real Time PCR Kit - Product Description 60
Table 122: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 61
Table 123: HPV Genotyping Assay - Cervical Cancer - Product Status 61
Table 124: HPV Genotyping Assay - Cervical Cancer - Product Description 61
Table 125: Goodgene Inc Pipeline Products & Ongoing Clinical Trials Overview 62
Table 126: GG HPV DNA Genotyping Chip - Product Status 62
Table 127: GG HPV DNA Genotyping Chip - Product Description 62
Table 128: Great Basin Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 129: Diagnostic Test - Human Papilloma Virus - Product Status 63
Table 130: Diagnostic Test - Human Papilloma Virus - Product Description 63
Table 131: HEALTH BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 64
Table 132: 3500Dx Genetic Analyzer - SureX HPV 25 Genotyping Assay Kit - Product Status 64
Table 133: 3500Dx Genetic Analyzer - SureX HPV 25 Genotyping Assay Kit - Product Description 64
Table 134: HistoGeneX NV Pipeline Products & Ongoing Clinical Trials Overview 65
Table 135: IHC Based Diagnostic Assay - HPV - Product Status 65
Table 136: IHC Based Diagnostic Assay - HPV - Product Description 65
Table 137: Homepoint Testing Pipeline Products & Ongoing Clinical Trials Overview 66
Table 138: HPV-Inform - Product Status 66
Table 139: HPV-Inform - Product Description 66
Table 140: IncellDx Inc Pipeline Products & Ongoing Clinical Trials Overview 67
Table 141: HPV OncoTect mRNA - Product Status 67
Table 142: HPV OncoTect mRNA - Product Description 67
Table 143: KogeneBiotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 68
Table 144: SuperFast HPV Low risk 5 Multiplex Real-time PCR Kit - Product Status 68
Table 145: SuperFast HPV Low risk 5 Multiplex Real-time PCR Kit - Product Description 68
Table 146: MEDITE Cancer Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 69
Table 147: Diagnostic Assay - HPV - Product Status 69
Table 148: Diagnostic Assay - HPV - Product Description 69
Table 149: MedNostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 70
Table 150: MedNetic HPV Immunoassay - Product Status 70
Table 151: MedNetic HPV Immunoassay - Product Description 70
Table 152: Monogram Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 71
Table 153: Human Papilloma Virus Assay - Product Status 71
Table 154: Human Papilloma Virus Assay - Product Description 71
Table 155: Novacyt SA Pipeline Products & Ongoing Clinical Trials Overview 72
Table 156: Genesig Kit - Human Papillomavirus 14 - Product Status 72
Table 157: Genesig Kit - Human Papillomavirus 14 - Product Description 72
Table 158: OncoHealth Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 73
Table 159: HPV E6 Analyte Specific Reagents Kit - Product Status 73
Table 160: HPV E6 Analyte Specific Reagents Kit - Product Description 73
Table 161: HPV E7 Analyte Specific Reagents Kit - Product Status 74
Table 162: HPV E7 Analyte Specific Reagents Kit - Product Description 74
Table 163: Pathogenica Inc Pipeline Products & Ongoing Clinical Trials Overview 75
Table 164: HPV Strain Genotyping Test - Product Status 75
Table 165: HPV Strain Genotyping Test - Product Description 75
Table 166: Provista Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 76
Table 167: Blood-Based Diagnostic Test - Cervical Cancer - Product Status 76
Table 168: Blood-Based Diagnostic Test - Cervical Cancer - Product Description 76
Table 169: Blood-Based Diagnostic Test - Oropharyngeal Cancer - Product Status 77
Table 170: Blood-Based Diagnostic Test - Oropharyngeal Cancer - Product Description 77
Table 171: Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 78
Table 172: QIAscreen - HPV Assay - Product Status 78
Table 173: QIAscreen - HPV Assay - Product Description 78
Table 174: QIAsymphony RGQ - HPV Assay - Product Status 79
Table 175: QIAsymphony RGQ - HPV Assay - Product Description 79
Table 176: Rheonix Inc Pipeline Products & Ongoing Clinical Trials Overview 80
Table 177: Rheonix CARD HPV Assay - Product Status 80
Table 178: Rheonix CARD HPV Assay - Product Description 80
Table 179: Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 81
Table 180: 15 High-risk Human Papillomavirus DNA Fluorescence Diagnostic Kit - Product Status 81
Table 181: 15 High-risk Human Papillomavirus DNA Fluorescence Diagnostic Kit - Product Description 81
Table 182: 15 High-risk Human Papillomavirus DNA Genotyping Diagnostic Kit - Product Status 82
Table 183: 15 High-risk Human Papillomavirus DNA Genotyping Diagnostic Kit - Product Description 82
Table 184: Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 83
Table 185: Diagnostic Test - High Risk HPV - Product Status 83
Table 186: Diagnostic Test - High Risk HPV - Product Description 83
Table 187: Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview 84
Table 188: AttoSense HPV Test - Product Status 84
Table 189: AttoSense HPV Test - Product Description 85
Table 190: AttoSense HPV-G Test - Product Status 85
Table 191: AttoSense HPV-G Test - Product Description 85
Table 192: AttoSense HPV-Q Test - Product Status 86
Table 193: AttoSense HPV-Q Test - Product Description 86
Table 194: The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 87
Table 195: Cervical HPV Staining Kit - Product Status 87
Table 196: Cervical HPV Staining Kit - Product Description 87
Table 197: TrovaGene Inc Pipeline Products & Ongoing Clinical Trials Overview 88
Table 198: HPV Diagnostic Test - Men - Product Status 88
Table 199: HPV Diagnostic Test - Men - Product Description 88
Table 200: University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 89
Table 201: Diagnostic Test - HPV Linked Head and Neck Cancer - Product Status 89
Table 202: Diagnostic Test - HPV Linked Head and Neck Cancer - Product Description 89
Table 203: University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 90
Table 204: Personalized Genomic Test - Cervical Cancer - Product Status 90
Table 205: Personalized Genomic Test - Cervical Cancer - Product Description 90
Table 206: ValiRx Plc Pipeline Products & Ongoing Clinical Trials Overview 91
Table 207: Diagnostic Test - HPV - Product Status 91
Table 208: Diagnostic Test - HPV - Product Description 91
Table 209: Yale University Pipeline Products & Ongoing Clinical Trials Overview 92
Table 210: Diagnostic Assay - Cervical Cancer - Product Status 92
Table 211: Diagnostic Assay - Cervical Cancer - Product Description 92
Table 212: Glossary 156

1.2 List of Figures
Figure 1: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Stage of Development 10
Figure 2: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Territory 11
Figure 3: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Regulatory Path 12
Figure 4: Human Papillomavirus (HPV) Diagnostic Tests - Pipeline Products by Estimated Approval Date 13
Figure 5: Human Papillomavirus (HPV) Diagnostic Tests - Ongoing Clinical Trials 14
  • Global Rapid Medical Diagnostic Kits Market Research Report 2017
    Published: 21-Nov-2017        Price: US 2900 Onwards        Pages: 124
    In this report, the global Rapid Medical Diagnostic Kits market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Rapid Medical Diagnostic Kits in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global In-Vitro Diagnostics (IVD) Market Size, Status and Forecast 2022
    Published: 17-Nov-2017        Price: US 3300 Onwards        Pages: 100
    This report studies the global In-Vitro Diagnostics (IVD) market, analyzes and researches the In-Vitro Diagnostics (IVD) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Roche - Siemens - Danaher - Abbott - BD - Alere - SYSMEX - BioMerieux - J&J - BIO-RAD - Hologic - KHB Market segment by Re......
  • Therapeutic Drug Monitoring (TDM) Market 2021: US, Europe, Japan--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 8500 Onwards        Pages: 0
    Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 313-page report from VPGMarketResearch.com contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and m......
  • France Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Pr......
  • Germany Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Pr......
  • Italy Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/P......
  • Japan Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2750 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/......
  • Spain Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation ReviewReview
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the Spanish therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/P......
  • UK Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Proca......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs